Keratitis and corneal melt with ketorolac tromethamine after conductive keratoplasty

Cornea. 2011 Apr;30(4):477-8. doi: 10.1097/ICO.0b013e3181ef6ec7.

Abstract

Purpose: To report a case of keratitis and corneal melt after conductive keratoplasty (CK) enhancement.

Method: Case report.

Results: A 52-year-old woman with emmetropic presbyopia had undergone previous CK for monovision and underwent CK enhancement 4 years later. Postoperatively, she was managed with ketorolac tromethamine 0.4% and developed keratitis and corneal melt.

Conclusions: This is the first reported case of keratitis and corneal melt associated with nonsteroidal antiinflammatory topical medications in a post-CK patient.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Corneal Diseases / chemically induced*
  • Corneal Diseases / drug therapy
  • Electrocoagulation*
  • Female
  • Humans
  • Keratitis / chemically induced*
  • Keratitis / drug therapy
  • Ketorolac Tromethamine / administration & dosage
  • Ketorolac Tromethamine / adverse effects*
  • Middle Aged
  • Prednisolone / analogs & derivatives
  • Prednisolone / therapeutic use
  • Presbyopia / drug therapy
  • Presbyopia / surgery*

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac Tromethamine
  • prednisolone acetate
  • Prednisolone